13D/13G Filings - Cidara Therapeutics Inc. (CDTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-09
5:37 pm
Purchase
2024-11-2613GCidara Therapeutics, Inc.
CDTX
Vivo Opportunity Fund Holdings L.P.600,157
5.500%
600,157increase
(New Position)
Filing
History
2024-12-04
4:15 pm
Purchase
2024-11-2613GCidara Therapeutics, Inc.
CDTX
Venrock Healthcare Capital Partners III L.P.1,129,097
9.990%
1,129,097increase
(New Position)
Filing
History
2024-12-03
4:34 pm
Purchase
2024-11-2613GCidara Therapeutics, Inc.
CDTX
TCG Crossover GP II, LLC1,005,901
9.200%
1,005,901increase
(New Position)
Filing
History
2024-11-26
5:32 pm
Purchase
2024-11-2613DCidara Therapeutics, Inc.
CDTX
RA CAPITAL MANAGEMENT L.P.1,092,796
9.990%
389,716increase
(+55.43%)
Filing
History
2024-11-14
4:22 pm
Purchase
2024-09-3013GCidara Therapeutics, Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P703,126
9.990%
703,126increase
(New Position)
Filing
History
2024-07-29
4:45 pm
Purchase
2024-07-1813GCidara Therapeutics, Inc.
CDTX
BCLS Fund III Investments LP703,080
9.990%
703,080increase
(New Position)
Filing
History
2024-07-29
4:31 pm
Purchase
2024-07-1813GCidara Therapeutics, Inc.
CDTX
Canaan XII L.P.1,400,000
9.990%
1,400,000increase
(New Position)
Filing
History
2024-07-25
4:16 pm
Purchase
2024-07-1813DCidara Therapeutics, Inc.
CDTX
RA CAPITAL MANAGEMENT L.P.703,080
9.990%
703,080increase
(New Position)
Filing
History
2024-02-14
4:51 pm
Sale
2023-12-3113GCidara Therapeutics, Inc.
CDTX
Nantahala Capital Management LLC77,337
1.700%
-141,036decrease
(-64.58%)
Filing
History
2024-02-14
10:18 am
Purchase
2023-12-3113GCidara Therapeutics, Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P463,776
9.990%
120,720increase
(+35.19%)
Filing
History
2024-02-14
10:02 am
Sale
2023-12-3113GCidara Therapeutics, Inc.
CDTX
Point72 Asset Management, L.P.62,511
1.400%
-130,889decrease
(-67.68%)
Filing
History
2023-02-14
4:58 pm
Sale
2022-12-3113GCidara Therapeutics, Inc.
CDTX
Nantahala Capital Management LLC218,373
6.100%
-45,150decrease
(-17.13%)
Filing
History
2023-02-14
4:23 pm
Sale
2022-12-3113GCidara Therapeutics, Inc.
CDTX
Point72 Asset Management, L.P.193,400
5.400%
-22,502decrease
(-10.42%)
Filing
History
2022-02-15
1:09 pm
Sale
2021-12-3113GCidara Therapeutics, Inc.
CDTX
Lytton, Laurence W.85,416
2.500%
-81,604decrease
(-48.86%)
Filing
History
2022-02-14
4:48 pm
Sale
2021-12-3113GCidara Therapeutics, Inc.
CDTX
Omega Fund V L.P.62,500
1.800%
-100,262decrease
(-61.60%)
Filing
History
2022-02-14
4:41 pm
Purchase
2021-12-3113GCidara Therapeutics, Inc.
CDTX
Point72 Asset Management, L.P.215,902
6.500%
5,902increase
(+2.81%)
Filing
History
2022-02-14
08:30 am
Purchase
2021-12-3113GCidara Therapeutics, Inc.
CDTX
Nantahala Capital Management LLC263,523
7.900%
263,523increase
(New Position)
Filing
History
2022-02-11
4:48 pm
Sale
2021-12-3113GCidara Therapeutics, Inc.
CDTX
BB Biotech AG0
0.000%
-141,125decrease
(Position Closed)
Filing
History
2021-12-16
5:16 pm
Purchase
2021-12-1413GCidara Therapeutics, Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P343,056
10.300%
119,982increase
(+53.79%)
Filing
History
2021-10-14
5:12 pm
Purchase
2021-10-1313GCidara Therapeutics, Inc.
CDTX
Point72 Asset Management, L.P.210,000
6.300%
210,000increase
(New Position)
Filing
History
Goto 0, 1, Next